Text from here

Press releases FY2020

No. Date Title Institution(s)
  9/3/2020 Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. iCONM, Cancer Institute Hospital, Medical Science – the University of Tokyo,Sapporo Medical University, Keio University Hospital, NanoCarrier Co., Ltd., Japan Agency for Medical Research and Development
  8/4/2020 Epirubicin-Loaded Nanomedicines Beat Immune Checkpoint
Blockade Resistance in Glioblastoma
iCONM, University of Tokyo
  7/27/2020 Developing a new strategy to selectively deliver therapies to the brain
Turning the problem into the solution: exploiting the impermeability
of the brain vasculature to target nano-vehicles to the brain
iCONM, University of Tokyo
  6/26/2020 Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
iCONM, National Institutes for Quantum and Radiological Science and Technology, University of Toky
  6/4/2020 Research and development focus on producing technology of the mRNA vaccine in preparation for the re-emergence of Covid-19 and / or further mutated species of “coronavirus” -Tokyo Metropolitan Institute of Medical Science and iCONM start collaborative research- iCONM、Tokyo Metropolitan Institute of Medical Science
  5/20/2020 Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain iCONM, University of Tokyo, Tokyo Medical and Dental University
  5/12/2020 Treat expectant mother while protecting baby with covering the medicine with nanocapsules. iCONM, KISTEC, The University of Tokyo
  4/2/2020 A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application iCONM、The University of Tokyo

Page Top